Patent ID: 11970543
Assignee: ARCUS BIOSCIENCES, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 11:
12. The anti-CD39 antibody of claim 1, wherein the antibody has a heavy chain variable region and a light chain variable region according to claim 1 and:
the heavy chain variable region has at least 95% sequence identity to SEQ ID NO: 27, and the light chain variable region has at least 95% sequence identity to SEQ ID NO: 31;
the heavy chain variable region has at least 95% sequence identity to SEQ ID NO: 58, and the light chain variable region has at least 95% sequence identity to SEQ ID NO: 60;
the heavy chain variable region has at least 95% sequence identity to SEQ ID NO: 58, and the light chain variable region has at least 95% sequence identity to SEQ ID NO: 61;
the heavy chain variable region has at least 95% sequence identity to SEQ ID NO: 58, and the light chain variable region has at least 95% sequence identity to SEQ ID NO: 62;
the heavy chain variable region has at least 95% sequence identity to SEQ ID NO: 58, and the light chain variable region has at least 95% sequence identity to SEQ ID NO: 63;
the heavy chain variable region has at least 95% sequence identity to SEQ ID NO: 59, and the light chain variable region has at least 95% sequence identity to SEQ ID NO: 61;
the heavy chain variable region has at least 95% sequence identity to SEQ ID NO: 59, and the light chain variable region has at least 95% sequence identity to SEQ ID NO: 60;
the heavy chain variable region has at least 95% sequence identity to SEQ ID NO: 59, and the light chain variable region has at least 95% sequence identity to SEQ ID NO: 62; or
the heavy chain variable region has at least 95% sequence identity to SEQ ID NO: 59, and the light chain variable region has at least 95% sequence identity to SEQ ID NO: 63.